Olli Yli-Harja

Olli Yli-Harja is a Professor in Biomedicine at Tampere University. His research spans oncology, pharmacology, and computational biology, with a focus on glioblastoma treatment and machine learning applications in biomedical contexts.

• Doctor of Science (Technology), Lappeenranta University of Technology (1989)
• Master of Science (Technology) in Automation Engineering, Lappeenranta University of Technology (1985)

His work intersects biomedicine and computational methods, targeting cancer therapies and dynamical systems modeling. Recent studies include adenosine receptor antagonists for glioblastoma and DNA methylation analysis in pediatric tumors.

Publications highlight trends in scientific machine learning, adenosine pharmacology, and epigenetic tumor mechanisms. Collaborations span pharmacology, genetics, and AI-driven biomedical research.

Activities include conference presentations, editorial board roles, and media appearances discussing cancer treatment innovations.